tiprankstipranks
RxSight sees FY24 revenue $139M-$140M, consensus $139.64M
The Fly

RxSight sees FY24 revenue $139M-$140M, consensus $139.64M

Gross margin in the range of 70% to 71%, up from previous guidance range of 68% to 70%; and Operating expenses at the low end of its previously provided guidance range of $135.0 to $136.0 million, including non-cash stock-based compensation expense, now also expected at the lower end of the previous guidance range of $29.0 to $30.0 million.

Pick the best stocks and maximize your portfolio:

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App